SEC Tracker
Get the app
CVSI · XBRL financial data

CV Sciences financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CVSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers4,0893,801*4,0023,9543,8653,884*3,6063,6203,2563,307*3,1952,985
Cost of revenue2,2462,059*2,1492,0942,0872,207*1,9481,7761,6771,636*1,6331,535
Gross profit1,8431,742*1,8531,8601,7781,677*1,6581,8441,5791,671*1,5621,450
Research and development4040*36282925*30502418*1818
Selling, general and administrative2,2402,591*2,4372,4152,0902,298*2,1391,9251,8301,728*1,8621,733
General and administrative—year only1,0021,248740996*960836710647*788708
Operating income (loss)(437)(889)*(620)(583)(341)(646)*11(131)(275)(75)*(318)(301)
Interest expense————11594*151130107129*931
Other income (expense)(10)11*(2)(1)(115)(94)*(151)(130)(107)(91)*—469
Income tax expense (benefit)0(9)*600(14)*7002*05
Net income (loss)(447)(869)*(628)(584)(456)(726)*(109)(261)(382)(206)*(643)(775)
Earnings per share, basic USD per share0.00(0.01)*0.000.000.000.00*0.000.000.000.00*0.000.00
Earnings per share, diluted USD per share0.00(0.01)*0.000.000.000.00*0.000.000.000.00*0.000.00
Weighted average shares, basic thousands of shares154,604156,454*163,075172,418182,261184,416*184,264184,264184,264184,264*186,920205,086
Weighted average shares, diluted thousands of shares154,604156,458*163,075172,418182,261184,416*184,264184,264184,264184,264*186,920205,086

Balance sheet

CSV

Fiscal quarters (CVSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents1,6431,317662477979454812886381278309266
Accounts receivable666431507639422522430545405402391348
Inventory5,7295,6555,7565,2065,0204,8974,3684,2164,0804,0873,9023,965
Prepaid and other current assets412535426410327370353295231366393300
Total current assets8,4507,9387,3516,7326,7486,2435,9635,9425,0975,1334,9954,879
Property and equipment, net399379319666490399364363349344329319
Right-of-use asset1951671394518194257472410347282215
Goodwill—3423407298159719881,0131,0101,0151,001999
Total assets9,6439,2008,4668,8868,3917,9277,7617,9506,9956,9626,7226,521
Accounts payable2,6232,3092,4602,3071,8861,9251,4961,4401,2141,0441,0801,059
Accrued liabilities3,3113,4223,2483,4613,4223,4242,8463,0032,8742,4472,6472,631
Current portion of long-term debt—————6777701,0234511,2627218
Total current liabilities6,0616,1155,9596,0316,1436,1095,2525,7054,7865,0005,1804,943
Long-term debt—————049820850438700
Lease liability, non-current925823233019115230162100370
Total liabilities6,1646,2976,1046,3786,2006,1325,8696,1475,4565,4945,2244,950
Accumulated deficit(83,718)(84,587)(85,215)(85,799)(86,255)(86,981)(87,090)(87,351)(87,733)(87,939)(88,582)(89,357)
Total stockholders' equity3,4792,9032,3622,5082,1911,7951,8921,8031,5391,4681,4981,571
Total liabilities and equity9,6439,2008,4668,8868,3917,9277,7617,9506,9956,9626,7226,521
Common shares outstanding (cover page) thousands of shares154,605163,228163,228180,651184,264184,264184,264184,264184,264193,458203,978225,829

Cash flows

CSV

Fiscal quarters (CVSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(447)(869)*(628)(584)(456)(726)*(109)(261)(382)(206)*(643)(775)
Stock-based compensation32*33*3037*87*104*118132*124*123*148148*
Depreciation and amortization58*59*6376*81*114*8258*31*21*2322*
Net cash from operating activities(19)*(114)*(518)(57)*(122)*(164)*(81)287*(259)*(354)*10120*
Purchases of property and equipment—year only00*0*18*4049*11*9*37*
Net cash from investing activities0*(156)*0(40)*34*(22)*(40)(49)*(11)*(9)*(3)(7)*
Net cash from financing activities(28)*(56)*(136)(87)*590*(335)*480(167)*(234)*258*(68)(54)*
Net change in cash(47)*(326)*(655)(185)*502*(525)*35874*(505)*(103)*31(43)*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
  • A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
CV Sciences2662,98520*225.8M— 10-QJun 30, 2026
Minerva Neurosciences24,652not reported(13,345)*47.7M5.6 quarters 10-QJun 30, 2026
Neuphoria Therapeutics19,866year only1,214*5.4M— 10-KJun 30, 2026
Sunshine Biopharma13,7489,264(918)*3.9M15.0 quarters 10-QJun 30, 2026
Zeo ScientifiX2,265not reportednot reported7.8M— 10-KTJun 30, 2026
Bolt Biotherapeutics12,8605(6,540)*1.9M2.7 quarters 10-QJun 30, 2026
Protagenic Therapeutics, Inc.\new566not reported(944)1.8M0.6 quarters 10-QJun 30, 2026
Intensity Therapeutics9,529not reported(2,340)*3.3M4.1 quarters 10-QJun 30, 2026
Biomerica2,7331,265(802)4.6M3.4 quarters 10-QAug 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.